Deal overview
| Target | SHIRE PLC |
|---|---|
| Bidder | TAKEDA PHARMACEUTICAL COMPANY LIMITED |
| Price | £0.00 Full version or £25.00 Light version |
| Publication Date | May 08, 2018 |
| Abstract | On 8 May 2018, the Japanese pharmaceutical group Takeda Pharmaceutical Company Limited ("Takeda") announced that it had agreed the terms of a recommended cash and share offer for the issued and to be issued share capital of the Jersey registered, London Stock Exchange listed pharmaceuticals group, Shire Plc ("Shire"). The announcement followed a series of proposed offers for ... |
| Number of pages (Full version) | 0 |
| Number of pages (Light version) | 2 |
| Format | Adobe Acrobat (Download Acrobat Reader) |
| Free Sample | Click Here to Download |
Purchase this report
Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.
©2024 M&A Monitor Limited
